Trial Finds Continuous Glucose Monitors Add Five Healthy Hours a Day in Type 2 Diabetes

· Science · United States

Continuous glucose monitors could transform diabetes management for millions of Americans with type 2 diabetes who do not take insulin, according to findings published in the New England Journal of Medicine. The monitors helped patients spend five more hours a day within a healthy blood sugar range. CGM use has spread quickly among people with type 1 diabetes and insulin-treated type 2 diabetes; this trial extends the evidence to patients managed without insulin, a much larger group. The result matters because time in range is an increasingly used measure of glucose control, and broader CGM adoption would affect device makers, insurers and clinical guidelines. The study's publication in a major journal is likely to feed into decisions about coverage and routine care.

Why it matters：Extending CGM evidence to non-insulin type 2 diabetes widens the potential market and could reshape coverage decisions and glucose-management guidelines worldwide.

Key points

  • Findings were published in the New England Journal of Medicine.
  • Patients gained five more hours a day in a healthy blood sugar range.
  • The study covers people with type 2 diabetes who do not take insulin.

Sources (original reporting)

More stories from this day